Jeremy L Wally

FDA Investigator Report

Designation: Program Management

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CBER CBER OCBQ DIS PSB

Total Inspections: 10

Total 483s Issued: 8

Total Warning Letters Issued: 0

Inspection Details

Longest Inspection: 9 days

Shortest Inspection: 1 days

Average Length of Inspection: 6.0 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Recent Inspections

DateCompanyCityCountryFEI Number483
2024-03-21Pace Analytical Inc.San GermanUnited States2623531
2024-03-08Citra Labs, LLCBraintreeUnited States1216032
2024-02-08Emergent Manufacturing Operations Baltimore LLC.BaltimoreUnited States3015448605
2022-06-09Seqirus IncHolly SpringsUnited States3007867647
2021-04-20Emergent Manufacturing Operations Baltimore LLC.BaltimoreUnited States3015448605
2016-07-22ID Biomedical Corp., a subsidary of GSK BiologicalsQuebecCanada3004835647
2015-06-26Merck Sharp & Dohme LLCWest PointUnited States2510592
2014-10-23Baxalta Belgium Manufacturing SALessinesBelgium3002806503
2014-05-06Ipsen Biopharm Ltd.WrexhamUnited Kingdom1000346340
2014-01-17Merck Sharp & Dohme LLCDurhamUnited States3006525584

Sign Up to get the complete report.

Download 483s and EIRs for Jeremy L Wally

Co-Inspectors

NameInspectionsLast Inspection
Priscilla M Pastrana22024
Chad R Burger22016
Jonah S Ufferfilge12024
Susan M Jackson12022
Debra M Emerson12021
Cody D Rickman12021
Ellen Huang12015
Destry M Sillivan12014
Qiao Y Bobo12014
Randa Melhem12014
Robert D Tollefsen12014
Seneca D Toms12014

Active Locations

Year-wise Inspection Count